Evidence map›Paper›PMID 39717184›Full record

ArticlePhysics and imaging in radiation oncology2024

Definition of a framework for volumetric modulated arc therapy plan quality assessment with integration of dose-, complexity-, and robustness metrics.

Tina Orovwighose, Bernhard Rhein, Oliver Schramm, Oliver Jäkel, Vania Batista

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tina OrovwighoseDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Bernhard RheinDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Oliver SchrammDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Oliver JäkelDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Vania BatistaDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Conventionally, the quality of radiotherapy treatment plans is assessed through visual inspection of dose distributions and dose-volume histograms. This study developed a framework to evaluate plan quality using dose, complexity, and robustness metrics. Additionally, a method for predicting plan robustness metrics using dose and complexity metrics was introduced for cases where plan robustness evaluation is unavailable or impractical. Materials and methods: The framework and prediction models were developed and validated using 103-bronchial Volumetric Modulated Arc Therapy (VMAT)-plans. The application of the framework was demonstrated using 25-VMAT-plans. To identify significant metrics for plan evaluation, 122-metrics were analysed and narrowed down using multivariate Spearman correlation. Metric limits were set with Statistical process control (SPC). Robustness metrics were predicted using multivariable or single linear regression models based on dose-and complexity-metrics. Results: Twenty-five-metrics were selected based on the amount and strength of correlations. R Conclusions: The developed framework enables early detection of sub-optimal, complex and non-robust treatment plans. The predictive model can be used when robustness evaluations are impractical.

Indexed as

Dose metricsPlan complexity metricsPlan robustness metricsRobustness predictionStatistical process control

Identifiers

PMID39717184
PMCPMC11663972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.